The Canadian Press - ONLINE EDITION

Enanta Pharmaceuticals shares climb in first trading day after IPO raises $56 million

Shares of Enanta Pharmaceuticals Inc. are rising in their trading debut on the Nasdaq exchange.

The Watertown, Mass., drug developer's stock is up more than 15 per cent, or $2.15, to $16.15 in morning trading. Meanwhile, the Nasdaq exchange is down slightly.

Enanta raised $56 million in an initial public offering of 4 million shares after pricing the stock at $14 per share, which was at the low end of its expected range. The shares are trading under the ticker symbol ENTA.

Enanta is developing potential hepatitis C treatments but has no products on the market yet. Its most advanced product is in late-stage testing.

The company wants to use offering proceeds for drug development and working capital.

You can comment on most stories on winnipegfreepress.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.

letters

Make text: Larger | Smaller

LATEST VIDEO

Claude Noel on the Jets' disappointing last game of the season

View more like this

Photo Store Gallery

  • MIKE APORIUS/WINNIPEG FREE PRESS STANDUP - pretty sunflower in field off HWY 206 near Bird's Hill Park Thursday August 09/2007
  • JOE BRYKSA/WINNIPEG FREE PRESS Local-(Standup photo)- A wood duck swims through the water with fall refections in Kildonan Park Thursday afternoon.

View More Gallery Photos

Poll

Should Victoria Day be renamed to honour aboriginals?

View Results

View Related Story

Ads by Google